Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950987 · ClinicalTrials.gov registry record · NA
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
A NA study of Li-Fraumeni Syndrome, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT02950987: Active NA study of Li-Fraumeni Syndrome, sponsored by Dana-Farber Cancer Institute.
NCT02950987 is a NA study of Li-Fraumeni Syndrome that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 150 participants, below the 2,051-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950987, a NA study of Li-Fraumeni Syndrome, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is evaluating Whole Body MRI as a possible screening tool to diagnose cancer for people with LFS and other inherited cancer predisposition syndromes.
Primary Outcome
Successful return of patients for four annual scans will be recorded.
Conditions Studied
Interventions
- DEVICE Whole Body MRI
Study Locations (3)
Massachusetts
- Dana Farber Cancer Institute - Boston
New York
- Memorial Sloan-Kettering Cancer Center - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-03 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT02950987 still lists
NCT02950987 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,051-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Li-Fraumeni Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Whole Body MRI is the first listed.
NCT02950987 reports a single indexed study location in Massachusetts, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02950987 about?
NCT02950987 is a clinical study titled "Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes". This study is evaluating Whole Body MRI as a possible screening tool to diagnose cancer for people with LFS and other inherited cancer predisposition syndromes.
What is the current status of trial NCT02950987?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2012-03. Estimated completion is 2027-12.
What conditions does trial NCT02950987 study?
This clinical trial studies the following conditions: Li-Fraumeni Syndrome.
What interventions are being tested in trial NCT02950987?
The interventions under investigation include: Whole Body MRI (DEVICE).
Who is sponsoring clinical trial NCT02950987?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02950987 being conducted?
This trial has 3 study locations across Massachusetts, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Li-Fraumeni Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Clinical and Genetic Studies of Li-Fraumeni Syndrome
RECRUITING
-
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
RECRUITING
-
Li-Fraumeni Syndrome/TP53 Biobank
RECRUITING
-
Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
RECRUITING
-
Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia